{"entity":{"type":"insider","cik":"0001417976","url":"/insider/0001417976","json_url":"/insider/0001417976.json","name":"Galligan Andrew H","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":20,"first":"2015-11-19","last":"2025-06-24","span_basis":"filed_date"},"name_variants":[{"name":"Galligan Andrew H","source":"filing","n_filings":20,"first_seen":"2015-11-19","last_seen":"2025-06-24"}],"transactions":[{"id":5075531,"accession":"0000950170-25-089617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-089617","line_url":"/filing/0000950170-25-089617#line-1","is_derivative":false,"issuer_cik":"0001327688","issuer_name":"OOMA INC","issuer_ticker":"OOMA","issuer_name_source":null,"issuer_url":"/issuer/0001327688","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12407.0,"shares_display":"12,407","price_per_share":12.4346,"price_display":"12.43","price_state":"stated","total_value":154276.0822,"total_display":"154,276.08","total_whole":"154,276","shares_owned_after":241081.0,"shares_owned_after_display":"241,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-23","filed_date":"2025-06-24","scope":"insider"},{"id":2681555,"accession":"0000950170-24-138441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-138441","line_url":"/filing/0000950170-24-138441#line-2","is_derivative":false,"issuer_cik":"0001327688","issuer_name":"OOMA INC","issuer_ticker":"OOMA","issuer_name_source":null,"issuer_url":"/issuer/0001327688","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14824.0,"shares_display":"14,824","price_per_share":14.56,"price_display":"14.56","price_state":"stated","total_value":215837.44,"total_display":"215,837.44","total_whole":"215,837","shares_owned_after":241932.0,"shares_owned_after_display":"241,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-19","scope":"insider"},{"id":3226628,"accession":"0001567619-20-000906","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-000906","line_url":"/filing/0001567619-20-000906#line-2","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17718.0,"shares_display":"17,718","price_per_share":120.1087,"price_display":"120.11","price_state":"stated","total_value":2128085.9466,"total_display":"2,128,085.95","total_whole":"2,128,086","shares_owned_after":53490.0,"shares_owned_after_display":"53,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-08","filed_date":"2020-01-10","scope":"insider"},{"id":2129153,"accession":"0001567619-20-000740","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-000740","line_url":"/filing/0001567619-20-000740#line-2","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2782.0,"shares_display":"2,782","price_per_share":120.0,"price_display":"120.00","price_state":"stated","total_value":333840.0,"total_display":"333,840.00","total_whole":"333,840","shares_owned_after":53490.0,"shares_owned_after_display":"53,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-06","filed_date":"2020-01-08","scope":"insider"},{"id":7868986,"accession":"0001567619-19-022263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-022263","line_url":"/filing/0001567619-19-022263#line-2","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":110.3928,"price_display":"110.39","price_state":"stated","total_value":1324713.6,"total_display":"1,324,713.60","total_whole":"1,324,714","shares_owned_after":53490.0,"shares_owned_after_display":"53,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-25","filed_date":"2019-11-26","scope":"insider"},{"id":8192251,"accession":"0001567619-19-021254","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-19-021254","line_url":"/filing/0001567619-19-021254","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18522.0,"shares_display":"18,522","price_per_share":103.69997450599287,"price_display":"103.70","price_state":"stated","total_value":1920730.9278,"total_display":"1,920,730.93","total_whole":"1,920,731","shares_owned_after":54665.0,"shares_owned_after_display":"54,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-11","filed_date":"2019-11-13","scope":"insider","n_lines":3},{"id":7980238,"accession":"0001209191-19-050510","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-050510","line_url":"/filing/0001209191-19-050510#line-1","is_derivative":false,"issuer_cik":"0001327688","issuer_name":"OOMA INC","issuer_ticker":"OOMA","issuer_name_source":null,"issuer_url":"/issuer/0001327688","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":10.496,"price_display":"10.50","price_state":"stated","total_value":262400.0,"total_display":"262,400.00","total_whole":"262,400","shares_owned_after":160984.0,"shares_owned_after_display":"160,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-23","scope":"insider"},{"id":8600859,"accession":"0001209191-19-049200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-049200","line_url":"/filing/0001209191-19-049200#line-1","is_derivative":false,"issuer_cik":"0001327688","issuer_name":"OOMA INC","issuer_ticker":"OOMA","issuer_name_source":null,"issuer_url":"/issuer/0001327688","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":12.3062,"price_display":"12.31","price_state":"stated","total_value":307655.0,"total_display":"307,655.00","total_whole":"307,655","shares_owned_after":185984.0,"shares_owned_after_display":"185,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2019-09-11","scope":"insider"},{"id":5953540,"accession":"0001140361-18-024283","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-024283","line_url":"/filing/0001140361-18-024283#line-2","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":76.137,"price_display":"76.14","price_state":"stated","total_value":532959.0,"total_display":"532,959.00","total_whole":"532,959","shares_owned_after":28192.0,"shares_owned_after_display":"28,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-14","filed_date":"2018-05-16","scope":"insider"},{"id":6302076,"accession":"0001140361-18-012018","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-012018","line_url":"/filing/0001140361-18-012018","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":80.10160942857142,"price_display":"80.10","price_state":"stated","total_value":560711.266,"total_display":"560,711.27","total_whole":"560,711","shares_owned_after":29652.0,"shares_owned_after_display":"29,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-05","scope":"insider","n_lines":2},{"id":4286872,"accession":"0001140361-17-043114","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-043114","line_url":"/filing/0001140361-17-043114#line-3","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":75.1057,"price_display":"75.11","price_state":"stated","total_value":525739.9,"total_display":"525,739.90","total_whole":"525,740","shares_owned_after":28192.0,"shares_owned_after_display":"28,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-14","filed_date":"2017-11-16","scope":"insider"},{"id":5329637,"accession":"0001140361-17-032394","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-032394","line_url":"/filing/0001140361-17-032394#line-4","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":82.3132,"price_display":"82.31","price_state":"stated","total_value":576192.4,"total_display":"576,192.40","total_whole":"576,192","shares_owned_after":11833.0,"shares_owned_after_display":"11,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-14","filed_date":"2017-08-16","scope":"insider"},{"id":4787931,"accession":"0001140361-17-021014","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-021014","line_url":"/filing/0001140361-17-021014","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":75.29790674666667,"price_display":"75.30","price_state":"stated","total_value":564734.3006,"total_display":"564,734.30","total_whole":"564,734","shares_owned_after":15837.0,"shares_owned_after_display":"15,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-15","filed_date":"2017-05-16","scope":"insider","n_lines":3},{"id":4671347,"accession":"0001140361-17-014934","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-014934","line_url":"/filing/0001140361-17-014934","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":94.46095247666666,"price_display":"94.46","price_state":"stated","total_value":2833828.5743,"total_display":"2,833,828.57","total_whole":"2,833,829","shares_owned_after":6833.0,"shares_owned_after_display":"6,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-05","scope":"insider","n_lines":3},{"id":4117732,"accession":"0001140361-17-010555","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-010555","line_url":"/filing/0001140361-17-010555","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":95.004108,"price_display":"95.00","price_state":"stated","total_value":712530.81,"total_display":"712,530.81","total_whole":"712,531","shares_owned_after":37133.0,"shares_owned_after_display":"37,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-03","scope":"insider","n_lines":2},{"id":2888840,"accession":"0001140361-16-087000","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-16-087000","line_url":"/filing/0001140361-16-087000","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":86.90050213333333,"price_display":"86.90","price_state":"stated","total_value":651753.766,"total_display":"651,753.77","total_whole":"651,754","shares_owned_after":32906.0,"shares_owned_after_display":"32,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-15","filed_date":"2016-11-16","scope":"insider","n_lines":4},{"id":2286619,"accession":"0001140361-16-076984","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-16-076984","line_url":"/filing/0001140361-16-076984","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":97.70554688,"price_display":"97.71","price_state":"stated","total_value":732791.6016,"total_display":"732,791.60","total_whole":"732,792","shares_owned_after":33294.0,"shares_owned_after_display":"33,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-17","scope":"insider","n_lines":3},{"id":3224305,"accession":"0001140361-16-066169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-066169","line_url":"/filing/0001140361-16-066169#line-2","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":64.7847,"price_display":"64.78","price_state":"stated","total_value":647847.0,"total_display":"647,847.00","total_whole":"647,847","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-16","filed_date":"2016-05-18","scope":"insider"},{"id":3046836,"accession":"0001140361-16-056412","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001140361-16-056412","line_url":"/filing/0001140361-16-056412","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.86714238,"price_display":"55.87","price_state":"stated","total_value":558671.4238,"total_display":"558,671.42","total_whole":"558,671","shares_owned_after":5200.0,"shares_owned_after_display":"5,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-03","scope":"insider","n_lines":7},{"id":8326753,"accession":"0001140361-15-042301","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-15-042301","line_url":"/filing/0001140361-15-042301","is_derivative":false,"issuer_cik":"0001417976","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001417976","owner_cik":"0001417976","owner_name":"Galligan Andrew H","owner_display_name":"Galligan Andrew H","owner_url":"/insider/0001417976","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":51.294455,"price_display":"51.29","price_state":"stated","total_value":1025889.1,"total_display":"1,025,889.10","total_whole":"1,025,889","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-17","filed_date":"2015-11-19","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":40,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001327688","name":"OOMA INC","url":"/issuer/0001327688","role":"Director","n_filings":4,"first_seen":"2019-09-11","last_seen":"2025-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001444380","name":"NEVRO CORP","url":"/issuer/0001444380","role":"Officer (Chief Financial Officer)","n_filings":16,"first_seen":"2015-11-19","last_seen":"2020-01-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001417976","retrieved_at":"2026-08-24T22:15:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}